Table 2.

Cumulative dose constraints (EBRT and SBRT boost).

Organ	Volume	EQD2*	Endpoint (>/Grade 3)
Spinal cord	Max point dose	45 Gy	Myelitis
Lung	<35%	20 Gy	Pneumonitis
Lung	<65%	5 Gy	Pneumonitis
Esophagus	10 cm	60 Gy	Stenosis/fistula
Heart	25%	40 Gy	Pericarditis
Brachial plexus	Max point dose	66 Gy	Neuropathy

^*With α/β of 3 used for late normal tissue effects except for spinal cord and brachial plexus were an α/β of 2 is used.